← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Mometasona currently has availability issues reported in 2 European registers: Spain, Italy.
Shortage ATC — · also listed as: MOMETASONA · MOMETASONE · data refreshed 6 October 2026
As of 6 October 2026, 2 of the 10 tracked registers list current availability issues for Mometasona, covering 2 affected product presentations. The longest-running open report was filed in Italy on 2026-01-01 and has now been open for about 9 months. Where agencies state a cause, commercial decisions or discontinuation lead with 1 of the 1 stated-cause reports. The furthest expected-resolution date currently on file is 2026-11-29; the earliest is 2026-11-29. Registers in Spain, Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇪🇸 Spain | Shortage MOMETASONA VISO FARMACEUTICA 1mg/g POMADA , 1 tubo de 60 g | 2026-10-05 | 2026-11-29 | Existen otros medicamentos con el mismo principio activo y misma vía. Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración. | register ↗ |
| 🇮🇹 Italy | Shortage RINALGIT | 2026-01-01 | — | Motivi commerciali Alternatives: AIFA: equivalents with the same active substance are available. | register ↗ |
Every individual register entry for Mometasona in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇪🇸 ES | MOMETASONA VISO FARMACEUTICA 1mg/g POMADA , 1 tubo de 60 g | Shortage | 2026-10-05 | 2026-11-29 | Existen otros medicamentos con el mismo principio activo y m |
| 🇮🇹 IT | RINALGIT | Shortage | 2026-01-01 | — | Motivi commerciali |
Yes. As of 6 October 2026, availability issues are reported in: Spain, Italy. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-11-29 to 2026-11-29. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
2 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Mometasona: AEMPS CIMA (Spain), AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Mometasona — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/mometasona/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Mometasona availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/mometasona/">Mometasona shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>